Venous Ethanol for Ventricular Tachycardia

A phase 2 trial registered on ClinicalTrials.gov. The registry status is recruiting. It plans to enroll 156 participants.

Also called NCT05511246

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; triple masking; primary purpose treatment
Phase
Phase 2
Enrolled
  • 156 participants (planned count) (from the registry)
Sponsor
Registry
  • NCT NCT05511246
Started
(actual) (from the registry)
Primary completion
(anticipated) (from the registry)
Completion
(anticipated) (from the registry)
Countries
United States (from the registry)
Registry status
  • Recruiting (from the registry)

Technical summary

Registry record NCT05511246. Randomized; triple masking; primary purpose treatment. Start 2023-04-12 (actual); primary completion 2027-12-12 (anticipated). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Venous Ethanol for Ventricular Tachycardia
Acronym
VELVET
Condition
Ventricular Tachycardia
Condition
Ischemic Cardiomyopathy
Intervention (Drug)
Venous ethanol
Intervention (Procedure)
Catheter ablation
Lead sponsor
The Methodist Hospital Research Institute (class: other)

Record details

Record id
cardio:ct-nct05511246
Content hash
68eb431680e744f1696c07b33d12a87e72dc2d2281334acdb416b9a835336486